The sources used here word this differently for each product. The label for Tri-Luma, a fluocinolone acetonide, hydroquinone and tretinoin cream listed in Drugs@FDA at 0.01%;4%;0.05%, states that there are no adequate and well-controlled studies in pregnant women and that the cream should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. This guide reports what each source says for the product it names. It does not say whether any product is safe or unsafe.
What the Tri-Luma label says about pregnancy
These points come from the Tri-Luma label, which includes prescribing information and a patient leaflet. They are not statements about hydroquinone 8% or about a compounded cream.
- The label says the cream contains the teratogen tretinoin, which may cause embryo-fetal death, altered fetal growth, congenital malformations, and potential neurologic deficits.
- It says the risk of teratogenesis due to topical exposure may be considered low. It adds that exposure during organogenesis in the first trimester is theoretically more likely to produce an adverse outcome than in later pregnancy.
- It reports that 13 women became pregnant during treatment with the cream. Most pregnancy outcomes are unknown. Three women gave birth to apparently healthy babies. One pregnancy was terminated prematurely, and another ended in miscarriage.
- The patient leaflet says to tell your doctor if you are pregnant or plan to become pregnant, and to tell your doctor right away if you become pregnant while using the cream.
The pregnancy reports are a short list of cases inside a label. Reports like these cannot show cause and effect.
What a hydroquinone 4% label and tretinoin sources say
The pregnancy section of a prescription hydroquinone 4% skin bleaching cream label states that it is not known whether topical hydroquinone can cause fetal harm in a pregnant woman or affect reproduction capacity. It adds that topical hydroquinone should be given to a pregnant woman only if clearly needed.
The Retin-A (tretinoin) cream and gel label says there are no adequate and well-controlled studies in pregnant women and that tretinoin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. The statement used here gives no strength.
The patient instructions in the same Retin-A label say that if you are pregnant, think you are pregnant, or are nursing a baby, consult your physician before using this medication. They give no strength either.
A systematic review and meta-analysis of first-trimester exposure to topical retinoids stated that its result may be used primarily in reassuring women who were inadvertently exposed during pregnancy. It also stated that the statistical power is not adequate to justify the use of topical retinoids during pregnancy. This guide uses only those two abstract statements, not any numbers.
What the sources say about breastfeeding
| Source and product | What the source says |
|---|---|
| Tri-Luma label, nursing mothers section | Because many drugs are secreted in human milk, caution should be exercised when the cream is administered to a nursing woman. Care should be taken to avoid contact between the nursed infant and the cream. |
| Retin-A (tretinoin) cream and gel label, patient instructions, no strength given | If you are nursing a baby, consult your physician before using this medication. |
| LactMed (NIH), topical hydroquinone, no strength given | Topical hydroquinone has not been studied during breastfeeding and is not contraindicated during breastfeeding. Some experts feel hydroquinone should not be used long term in nursing mothers. |
What this does not tell you
These are statements from labels, one reference page and one review abstract, reported in the sources' own terms. Each is about a named product or ingredient, not about hydroquinone 8% or a compounded cream. The sources used here report no trial of hydroquinone 8% or of the blend with tretinoin, niacinamide and vitamin C, so statements about 4% products or other combinations cannot be assumed to apply. The Tri-Luma pregnancy reports cannot show cause and effect. A licensed provider makes treatment decisions, and the Tri-Luma patient leaflet tells readers to tell their doctor if they are pregnant or plan to become pregnant. This guide does not say whether hydroquinone is safe or unsafe in pregnancy or breastfeeding.